Paushak Ltd (PAUSHAKLTD) is currently trading at 618.75 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.

Paushak Limited is India’s largest phosgene-based speciality chemicals manufacturer producing isocyanates, chloroformates, carbamoyl chlorides, carbamates and related intermediates for pharmaceuticals, agrochemicals, dyes, plastics and perfumery industries, operating a Responsible Care certified site near Vadodara with integrated phosgene and downstream multiproduct facilities. Financials for quarter ended 30 September 2025 show revenue from operations of Rs.5,878 lakhs and half-year revenue of Rs.11,466 lakhs, with H1 profit after tax of Rs.2,065 lakhs and basic H1 EPS of Rs.66.99, reflecting resilient revenue while profitability moderated year-on-year due to tax and deferred tax impacts. The balance sheet displays large ongoing investment: non-current assets increased to Rs.51,546 lakhs driven by CWIP and PPE, while non-current borrowings rose to Rs.5,400 lakhs, signalling active funding for capacity expansion and strategic plant investments that materially change asset base and future production capability. Paushak’s unique operational moat is long experience in phosgene handling and toll manufacturing expertise, plus a state-of-the-art phosgene plant (reported 14,400 MT/year) and downstream multipurpose units, positioning the company as a critical supplier to regulated and specialty end-markets with high barriers to entry. Corporate actions in H1FY26 included share capital reclassification, stock split/sub-division and a 3:1 bonus issue effective October 2025, indicating management focus on improving share liquidity and aligning capital structure after sustained investment and growth initiatives.

Over the past 52 weeks, Paushak Ltd has traded between a low of ₹343.00 and a high of ₹881.00. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.

Paushak Ltd has a market capitalization of approximately 1,527.37. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.

Paushak Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 32.30 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.

Based on its market capitalization of 1,527.37 Cr, Paushak Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.

Paushak Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.

The Price-to-Earnings (PE) ratio of Paushak Ltd is 32.30. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.

Paushak’s upcoming Q2 FY27 results are scheduled via a board meeting on 16 October 2026.

FY26 revenue from operations was ₹218.60 crore and profit after tax was ₹39.33 crore, based on audited results for the year ended 31 March 2026.